US2021052516A1PendingUtilityA1
Method for increasing akkermansia in intestinal bacterial flora by ingesting astaxanthin
Est. expiryFeb 2, 2038(~11.5 yrs left)· nominal 20-yr term from priority
A61K 31/122A61P 1/00A61K 9/0056
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for increasing bacteria belonging to the genus Akkermansia in an intestinal bacterial flora, comprising the step of ingesting a composition containing astaxanthin.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of increasing a percentage of bacteria belonging to the genus Akkermansia in an intestinal bacterial flora, and decreasing a percentage of at least bacteria belonging to Clostridia and Lactobacillus in the intestinal bacterial flora, in a patient in need of such an increase and such a decrease, the method comprising administering to such a patient a composition containing astaxanthin, wherein a daily amount of said astaxanthin administered is 1 to 40 mg.
2 . The method of claim 1 , wherein said bacteria belonging to the genus Akkermansia are Akkermansia muciniphila.
3 . The method of claim 1 , wherein said composition containing astaxanthin is administered so that a blood astaxanthin concentration becomes more than 0 and no more than 600 ng/ml.
4 . The method of claim 1 , wherein said composition containing astaxanthin is ingested for ameliorating a symptom of irritable bowel syndrome (IBS).
5 . The method of claim 1 , wherein said daily amount of said astaxanthin is 1 to 2 mg.
6 . The method of claim 1 , wherein said daily amount of said astaxanthin is 6 to 40 mg.Join the waitlist — get patent alerts
Track US2021052516A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.